USTEKINUMAB-TTWE
- Product NDC
- 82009-161
- 11-digit product format
- 820090161
- Labeler code
- 82009
- Product ID
- 82009-161_cb6d8d30-9458-42ed-8aee-2aae13f4760b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ustekinumab-ttwe
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Quallent Pharmaceuticals Health LLC
- Application
- BLA761373
- Marketing category
- BLA
- Marketing start
- 2025-04-15
- Substance
- USTEKINUMAB
- Active strength
- 45 mg/.5mL
- Pharmacologic classes
- Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- USTEKINUMAB-TTWE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| USTEKINUMAB | 45 mg/.5mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | FU77B4U5Z0 |
| Rxcui | 2705557, 2705568, 2705575, 2713885 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9101c6a6-2dd0-4586-9db6-ccb20dc679c9 | Product name | 2 | 20171206 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82009-161-94 | USTEKINUMAB-TTWE | 0.5 mL in 1 VIAL | INJECTION, SOLUTION | 0.5 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 82009-161-94 | ML - Milliliter | 82009-161 | 67446eaf-fc9f-49d0-a659-fd99437d1084 | 1 | 2026-03-17 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2705557 | ustekinumab-ttwe 130 MG in 26 ML Injection | PSN | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2713885 | ustekinumab-ttwe 45 MG in 0.5 ML Injection | PSN | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705568 | ustekinumab-ttwe 45 MG in 0.5 ML Prefilled Syringe | PSN | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705575 | ustekinumab-ttwe 90 MG in 1 ML Prefilled Syringe | PSN | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2713885 | 0.5 ML ustekinumab-ttwe 90 MG/ML Injection | SCD | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705568 | 0.5 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe | SCD | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705575 | 1 ML ustekinumab-ttwe 90 MG/ML Prefilled Syringe | SCD | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705557 | 26 ML ustekinumab-ttwe 5 MG/ML Injection | SCD | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705557 | ustekinumab-ttwe 130 MG per 26 ML Injection | SY | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2713885 | ustekinumab-ttwe 45 MG per 0.5 ML Injection | SY | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705568 | ustekinumab-ttwe 45 MG per 0.5 ML Prefilled Syringe | SY | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
| 2705575 | ustekinumab-ttwe 90 MG per 1 ML Prefilled Syringe | SY | 2b34392a-ecf6-41bd-8706-d4e9f0b25da8 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 82009-161-94 | 82009016194 | .5 mL in 1 VIAL (82009-161-94) | 2026-02-15 | No | No | Current |